Table 4 Immunohistochemical characteristics of basal cell neoplasms and adenoid cystic carcinomas
BCACs (n=7) | BCAs with ci. (n=10) | BCAs without ci. (n=10) | ACCs (n=10) | |
|---|---|---|---|---|
Cytokeratin 5/6* | 7 (100%) | 9 (90%) | 10 (100%) | 3 (30%) |
S100P protein | 0 (0%) | 1 (10%) | 1 (10%) | 5 (50%) |
β-catenin** | 7 (100%) | 7 (70%) | 10 (100%) | 0 (0%) |
CD117 | 4 (57%) | 6 (60%) | 10 (100%) | 10 (100%) |
EGFR | 3 (43%) | 2 (20%) | 9 (90%) | 5 (50%) |
p53 | 0 (0%) | 1 (10%) | 2 (20%) | 6 (60%) |
Ki-67$ | 0 (0%) | 2 (20%) | 2 (20%) | 10 (100%) |